Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92,189,700
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
37,333,019
-
Shares change
-
+3,229,592
-
Total reported value, excl. options
-
$202,972,596
-
Value change
-
+$14,914,954
-
Put/Call ratio
-
15%
-
Number of buys
-
61
-
Number of sells
-
-47
-
Price
-
$5.43
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2022
133 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q2 2022.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,333,019 shares
of 92,189,700 outstanding shares and own 40% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (6,000,000 shares), BlackRock Inc. (4,049,786 shares), Avidity Partners Management LP (2,950,000 shares), PICTET ASSET MANAGEMENT SA (2,689,227 shares), FARALLON CAPITAL MANAGEMENT LLC (2,203,895 shares), VANGUARD GROUP INC (1,992,363 shares), Rokos Capital Management LLP (1,907,509 shares), FMR LLC (1,524,331 shares), Assenagon Asset Management S.A. (1,109,929 shares), and ALKEON CAPITAL MANAGEMENT LLC (873,549 shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.